ScholarGate
Msaidizi

Linganisha mbinu

Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.

Njia ya Chou-Talalay×Kinetiki ya Michaelis-Menten×Uundaji wa Kimodelia wa Madhara ya Dawa kwa Idadi ya Watu×
NyanjaFamakolojiaFamakolojiaFamakolojia
FamiliaProcess / pipelineProcess / pipelineProcess / pipeline
Mwaka wa asili198319131992
MwanzilishiTing-Chao Chou and Paul TalalayLeonor Michaelis and Maud MentenLewis Sheiner and Stephen Roush
Ainasynergy quantificationmechanistic modeldose-response modeling
Chanzo asiliaChou, T. C., & Talalay, P. (1983). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27-55. DOI ↗Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗
Majina mbadalaCI method, Chou method, median-effect analysisMM kinetics, Michaelis constant, VmaxPopPD, population PD, hierarchical PD modeling
Zinazohusiana323
MuhtasariThe Chou-Talalay method is a quantitative framework for analyzing drug interactions, developed by Ting-Chao Chou and Paul Talalay in 1983. It combines median-effect principle with the combination index (CI) to provide rigorous, model-independent assessment of synergistic, additive, or antagonistic drug effects.Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics.Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction.
ScholarGateSeti ya data
  1. v1
  2. 2 Vyanzo
  3. PUBLISHED
  1. v1
  2. 2 Vyanzo
  3. PUBLISHED
  1. v1
  2. 2 Vyanzo
  3. PUBLISHED

Nenda kwenye utafutaji Pakua slaidi

ScholarGateLinganisha mbinu: Chou-Talalay Method · Michaelis-Menten Kinetics · Population Pharmacodynamics. Imepatikana 2026-06-20 kutoka https://scholargate.app/sw/compare